Christelle de la Fouchardière

institut paoli calmettes

57H指数

379论文数

2.8W被引数

收录论文 151

发表时间

EGFR targeting with afatinib and cetuximab versus cetuximab alone in chemorefractory wild-type RAS metastatic colorectal cancer. A randomized phase II study with circulating tumour cell analysis.使用阿法替尼和西妥昔单抗靶向EGFR与单独使用西妥昔单抗在化疗耐药的RAS野生型转移性结直肠癌中的比较：一项含循环肿瘤细胞分析的随机II期研究

Clinical Colorectal Cancer

IF3.2

2026-09-18

PREAI

Victor Simmet; Astrid Lièvre; Emmanuelle Samalin; Hélène Senellart; Christelle De La Fouchardière; Christophe Borg; Antoine Adenis; David Malka; Véronique Guerin-Meyer; Ludovic Evesque; Meher Ben Abdelghani; Julien Edeline; Thierry André; Francois Ghiringhelli; Jean-Luc Raoul; Laure Monard; Sophie Gourgou; Jaafar Bennouna

Is pembrolizumab as safe and efficient as neoadjuvant treatment in localized dMMR/MSI esophagogastric cancers? Results from the IMHOTEP phase II study 帕博利珠单抗作为局部dMMR/MSI食管胃癌的新辅助治疗是否安全有效？——IMHOTEP II期研究的结果

ESMO Open

IF8.3

2026-09-09

OAAI

C. Coutzac; A. Zaanan; A. de Montfort; E. Soularue; R. Cohen; S. Le Sourd; G. Piessen; V. Hautefeuille; M. Ben Abdelghani; E. Blanc; M. Svrcek; E. Samalin; D. Pérol; C. de la Fouchardière

Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 – GRACIE trial 伊沃内司单抗联合化疗在晚期或转移性胃癌（GC）或食管胃结合部癌（EGJC）中的应用：UCGI 52 – GRACIE试验

Digestive and Liver Disease

IF3.8

2026-08-30

OAAI

Judith Raimbourg; Damien Botsen; Simon Pernot; Valérie Boige; Mélanie Dos Santos; Clélia Coutzac; Nicolas De Sousa Carvalho; Cristina Smolenschi; Christelle de la Fouchardière

Pragmatism in academic gastrointestinal cancer clinical trials: an analysis of trials conducted by the EORTC Gastrointestinal Tract Cancer Group and the Unicancer Gastrointestinal Group 学术性消化道癌症临床研究中的实用主义：对EORTC消化道癌症组和Unicancer消化道组开展的研究的分析

European Journal of Cancer

IF7.1

2026-05-15

OAAI

Hannah C Puhr; Fabio Cardoso Borges; Laure Monard; Christelle De la Fouchardière; Jose Pais Silva; Elizabeth C Smyth; Denis Lacombe; Hanneke WM van Laarhoven

Survival outcomes in POD1UM-303/InterAACT-2: a phase 3 study of retifanlimab plus carboplatin–paclitaxel in first-line advanced squamous anal cancer POD1UM-303/InterAACT-2研究中瑞复健联合卡铂–紫杉醇治疗一线晚期鳞状细胞肛癌的生存结局：一项Ⅲ期研究

Annals of Oncology

IF65.4

2026-05-05

OAAI

S. Rao; E. Samalin-Scalzi; L. Evesque; M. Ben Abdelghani; F. Morano; A. Roy; L. Dahan; S. Tamberi; A.S. Dhadda; M.G. Zampino; N. Casanova; R. Guimbaud; A. Lievre; J. Maurel; P. Zhang; M.C. Munteanu; M. Jones; C. de la Fouchardiere; A. Takashima; M. Fakih

Neoadjuvant immune checkpoint inhibitors for localized dMMR/MSI-H gastric cancer: a meta-analysis 局部dMMR/MSI-H胃癌的新辅助免疫检查点抑制剂治疗：一项Meta分析

ESMO Open

IF8.3

2026-02-12

OAAI

W.K. Schwengber; R.A. Pereira; L.F. Leite da Silva; M. Tumelero; G. Lenz; I. Michelon; K. Chung; P.L.S. Uson Junior; T. Bekaii-Saab; C. de la Fouchardière; M.B. Sonbol

The Impact of the COVID-19 Pandemic on an Immunocompromised Patient with Allogeneic Haematopoietic Stem Cell Transplant: A Dual Perspective from Patient and Physician Standpoints COVID-19疫情对一名接受异基因造血干细胞移植的免疫抑制患者的影响：来自患者和医师双重视角的研究

Oncology and Therapy

IF3.2

2025-08-25

OAAI

Stephanie Nguyen; Isabelle

ESMO Open

IF8.3

2025-08-05

OAAI

D. Melisi; T. Macarulla; C. De La Fouchardière; R.A. Pazo Cid; S.R. Chandana; I. Kiss; W.J. Lee; T.O. Goetze; E. Van Cutsem; A.S. Paulson; T. Bekaii-Saab; S. Pant; R.A. Hubner; F. Maxwell; L. Zhang; F. Benzaghou; E.M. O’Reilly; Z.A. Wainberg

Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASE 经放疗或放化疗后肛管鳞状细胞癌的挽救性腹会阴联合切除术：法国前瞻性队列FFCD-ANABASE分析

european journal of oncology

IF0

2025-07-28

PREAI

Clara Naessens; Cécile Evin; Karine Le-Malicot; Claire Lemanski; Magali Rouffiac; David Tougeron; Laurent Quero; Mounira El Demery; Ludovic Evesque; Laurent Alcaraz; Mathieu Minsat; Astrid Lièvre; Franck Drouet; Vincent Hautefeuille; Laurianne Plastaras; Elodie Menager-Tabourel; Nabil Baba-Hamed; Philippe Ronchin; Anne-Agathe Serre; Christophe Locher; Christelle De la Fouchardière; Florence Huguet; Véronique Vendrely

FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA phase II randomized trial FOLFIRINOX或FOLFOX用于局部晚期或转移性小肠腺癌：PRODIGE 86 – FFCD-GONO – ENGIC 02 – FOLFIRINOX SBA II期随机试验

Digestive and Liver Disease

IF3.8

2025-07-28

OAAI

Thomas Aparicio; Anthony Turpin; Aziz Zaanan; Christelle de la Fouchardière; Karine Le Malicot; Sara Lonardi; Dominik Paul Modest; Richard Wilson; Chiara Cremolini; Alexej Ballhausen; Janet Graham; Annika Kurreck; Meriem Guarssifi; Magali Svrcek; Pierre Laurent-Puig; Sylvain Manfredi

Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study 错配修复缺陷型转移性结直肠癌患者中肌少症、GDF-15与纳武利尤单抗联合伊匹木单抗疗效的相互作用：GERCOR NIPICOL II期研究的最终生存分析

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2025-05-19

OAAI

Depotte, Leonard; Nay, Paula; Borg, Christophe; Meurisse, Aurelia; Henriques, Julie; Bennouna, Jaafar; de la Fouchardiere, Christelle; Tougeron, David; Mazard, Thibault; Chibaudel, Benoist; Tournigand, Christophe; Vernerey, Dewi; Pigneur, Frederic; Andre, Thierry; Cohen, Romain

Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative 促进欧洲胃肠道癌症大型跨国学术临床研究：ENGIC（欧洲胃肠道癌症网络）倡议

ESMO OPEN

IF8.3

2025-05-01

OAAI

Taieb, J.; Seligmann, J.; Modest, D.; Girault, C.; Rivera, F.; Mahillo, E.; Osterlund, P.; Pfeiffer, P.; Malka, D.; Louvet, C.; Siebenhuner, A. R.; Morf, C.; de la Fouchardiere, C.; Monard, L.; Koopman, M.; Vink, G.; Borbath, I.; Dewever, L.; Adams, R.; Reinacher-Schick, A.; Pietrantonio, F.; Lonardi, S.; Aparicio, T.; Cremolini, C.

Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study 瑞戈非尼联合伊立替康作为转移性胃食管腺癌的二线治疗：PRODIGE 58-UCGI35-REGIRI Unicancer随机II期研究的结果

ESMO OPEN

IF8.3

2025-05-01

OAAI

Samalin, E.; Evesque, L.; Turpin, A.; de la Fouchardiere, C.; Khemissa-Akouz, F.; Bouche, O.; Muller, M.; Dermeche, S.; Botsen, D.; Tougeron, D.; Zaanan, A.; Ben Abdelghani, M.; Guardiola, E.; Dubreuil, O.; Ly, V. Le Brun; Hennequin, A.; Watson, S.; Sefrioui, D.; Lecomte, T.; Carvalho, N. De Sousa; Hulin, A.; Crapez, E.; Castan, F.; Senellart, H.

TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial TFOX与FOLFOX在HER2阴性晚期胃或胃食管结合部腺癌患者一线治疗中的比较（PRODIGE 51-FFCD-GASTFOX）：一项开放标签、多中心、随机、III期临床试验

lancet oncology

IF0

2025-04-23

PREAI

Aziz Zaanan; Olivier Bouché; Christelle de la Fouchardière; Karine Le Malicot; Simon Pernot; Christophe Louvet; Pascal Artru; Valérie Le Brun Ly; Kais Aldabbagh; Faiza Khemissa-Akouz; Thierry Lecomte; Hélène Castanie; Margot Laly; Damien Botsen; Gael Roth; Emmanuelle Samalin; Marie Muller; Gilles Breysacher; Sylvain Manfredi; Jean-Marc Phelip; Julien Taieb

Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study 帕博利珠单抗与化疗在微卫星高度不稳定或错配修复缺陷型转移性结直肠癌中的应用比较：随机III期KEYNOTE-177研究的5年随访结果

ANNALS OF ONCOLOGY

IF65.4

2025-03-01

PREAI

Andre, T.; Shiu, K. -k.; Kim, T. W.; V. Jensen, B.; Jensen, L. H.; Punt, C. J. A.; Smiths, D.; Garcia-Carbonero, R.; Alcaide-Garcia, J.; Gibbs, P.; de la Fouchardiere, C.; Rivera, F.; Elez, E.; Le, D. T.; Yoshino, T.; Zuo, Y.; Fogelmans, D.; Adelbergs, D.; Diaz, L. A.

Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2024-11-28

PREAI

Andre, Thierry; Elez, Elena; Van Cutsem, Eric; Jensen, Lars Henrik; Bennouna, Jaafar; Mendez, Guillermo; Schenker, Michael; de la Fouchardiere, Christelle; Limon, Maria Luisa; Yoshino, Takayuki; Li, Jin; Lenz, Heinz-Josef; Manzano Mozo, Jose Luis; Tortora, Giampaolo; Garcia-Carbonero, Rocio; Dahan, Laetitia; Chalabi, Myriam; Joshi, Rohit; Goekkurt, Eray; Braghiroli, Maria Ignez; Cil, Timucin; Cela, Elvis; Chen, Tian; Lei, Ming; Dixon, Matthew; Abdullaev, Sandzhar; Lonardi, Sara

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial

ANNALS OF ONCOLOGY

IF65.4

2024-10-01

PREAI

Conroy, T.; Castan, F.; Etienne, P. -l.; Rio, E.; Mesgouez-Nebout, N.; Evesque, L.; Vendrely, V.; Artignan, X.; Bouche, O.; Gargot, D.; Boige, V.; Bonichon-Lamichhane, N.; Louvet, C.; Morand, C.; de la Fouchardiere, C.; Boileve, A.; Delaye, M.; Gourgou, S.; Pezzella, V.; Borg, C.

Atezolizumab plus UCPvax telomerase CD4 TH1-inducer cancer vaccine for the treatment of chemorefractory HPV plus cancers: Safety and efficacy results of the VolATIL phase II study 阿特珠单抗联合UCPvax端粒酶CD4 TH1诱导剂癌症疫苗治疗化疗耐药的HPV阳性癌症：VolATIL II期研究的疗效与安全性结果

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Mansi, L.; Ghiringhelli, F.; de la Fouchardiere, C.; You, B.; Kalbacher, E.; Bazan, F.; Legat, C. Fagnoni; Meynard, G.; Maurina, T.; Vienot, A.; Vernerey, D.; Meurisse, A.; Fumet, J-D.; Kroemer, M.; Tanang, A.; Rebucci-Peixoto, M.; Spehner, L.; Kim, S.; Adotevi, O.; Borg, C.

Acquired genomic alterations on first-line chemotherapy (CT) plus cetuximab in advanced colorectal cancer (mCRC): Circulating tumor (ct)DNA analysis of the randomized phase II trial TIME-PRODIGE-28 晚期结直肠癌(mCRC)一线化疗(CT)联合西妥昔单抗治疗后获得的基因组改变：TIME-PRODIGE-28随机II期试验的循环肿瘤(ct)DNA分析

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Boige, V.; Bouche, O.; Mulot, C.; Evesque, L.; Ben Abdelghani, M.; Phelip, J. M.; Mineur, L.; Galais, M. P.; Villing, A-L.; Hautefeuille, V.; de la Fouchardiere, C.; Genet, D.; Lassoued, S.; Carnot, A.; Mitry, E.; Jacquot, S.; Serazin, D.; Brument, E.; Winter, A.; Blons, H.

Efficacy of surgical gloves (SG) as compression therapy to prevent oxaliplatin-induced peripheral neuropathy (PN): The ELEGANT trial 奥沙利铂诱导性周围神经病变（PN）预防中手术手套（SG）作为加压疗法的疗效：ELEGANT试验

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Joureau-Chabert, A.; Dronne, W.; Ouldbey, Y.; Coutzac, C.; Chanel, E.; Blanc, E.; Cattey-Javouhey, A.; Evora, S.; Barry, A.; Montagnier, V.; Bourne-Branchu, V.; Arbault, C.; Siess, C.; Vandevoorde, K.; de la Fouchardiere, C.

研究方向